143 related articles for article (PubMed ID: 18516683)
1. Caspase-8 and its inhibitors in RCCs in vivo: the prominent role of ARC.
Heikaus S; Kempf T; Mahotka C; Gabbert HE; Ramp U
Apoptosis; 2008 Jul; 13(7):938-49. PubMed ID: 18516683
[TBL] [Abstract][Full Text] [Related]
2. Expression of death-associated protein kinase during tumour progression of human renal cell carcinomas: hypermethylation-independent mechanisms of inactivation.
Wethkamp N; Ramp U; Geddert H; Schulz WA; Florl AR; Suschek CV; Hassan M; Gabbert HE; Mahotka C
Eur J Cancer; 2006 Jan; 42(2):264-74. PubMed ID: 16386893
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of cFLIP(L) in colonic adenocarcinoma.
Ryu BK; Lee MG; Chi SG; Kim YW; Park JH
J Pathol; 2001 May; 194(1):15-9. PubMed ID: 11329136
[TBL] [Abstract][Full Text] [Related]
4. Expression of CD9/motility-related protein 1 (MRP-1) in renal parenchymal neoplasms: consistent expression in papillary and chromophobe renal cell carcinomas.
Kuroda N; Inoue K; Guo L; Miyazaki E; Hayashi Y; Naruse K; Toi M; Hiroi M; Shuin T; Enzan H
Hum Pathol; 2001 Oct; 32(10):1071-7. PubMed ID: 11679941
[TBL] [Abstract][Full Text] [Related]
5. FHIT expression in clear cell renal carcinomas: versatility of protein levels and correlation with survival.
Ramp U; Caliskan E; Ebert T; Karagiannidis C; Willers R; Gabbert HE; Gerharz CD
J Pathol; 2002 Apr; 196(4):430-6. PubMed ID: 11920739
[TBL] [Abstract][Full Text] [Related]
6. PIDDosome expression and the role of caspase-2 activation for chemotherapy-induced apoptosis in RCCs.
Heikaus S; Pejin I; Gabbert HE; Ramp U; Mahotka C
Cell Oncol; 2010; 32(1-2):29-42. PubMed ID: 20208132
[TBL] [Abstract][Full Text] [Related]
7. Increased RANKL expression is related to tumour migration and metastasis of renal cell carcinomas.
Mikami S; Katsube K; Oya M; Ishida M; Kosaka T; Mizuno R; Mochizuki S; Ikeda T; Mukai M; Okada Y
J Pathol; 2009 Aug; 218(4):530-9. PubMed ID: 19455604
[TBL] [Abstract][Full Text] [Related]
8. Disturbed balance of expression between XIAP and Smac/DIABLO during tumour progression in renal cell carcinomas.
Yan Y; Mahotka C; Heikaus S; Shibata T; Wethkamp N; Liebmann J; Suschek CV; Guo Y; Gabbert HE; Gerharz CD; Ramp U
Br J Cancer; 2004 Oct; 91(7):1349-57. PubMed ID: 15328523
[TBL] [Abstract][Full Text] [Related]
9. High expression of the Cap43 gene in infiltrating macrophages of human renal cell carcinomas.
Nishie A; Masuda K; Otsubo M; Migita T; Tsuneyoshi M; Kohno K; Shuin T; Naito S; Ono M; Kuwano M
Clin Cancer Res; 2001 Jul; 7(7):2145-51. PubMed ID: 11448934
[TBL] [Abstract][Full Text] [Related]
10. miR-212 increases tumor necrosis factor-related apoptosis-inducing ligand sensitivity in non-small cell lung cancer by targeting the antiapoptotic protein PED.
Incoronato M; Garofalo M; Urso L; Romano G; Quintavalle C; Zanca C; Iaboni M; Nuovo G; Croce CM; Condorelli G
Cancer Res; 2010 May; 70(9):3638-46. PubMed ID: 20388802
[TBL] [Abstract][Full Text] [Related]
11. Expression of cellular FLICE inhibitory protein, caspase-8, and protease inhibitor-9 in Ewing sarcoma and implications for susceptibility to cytotoxic pathways.
de Hooge AS; Berghuis D; Santos SJ; Mooiman E; Romeo S; Kummer JA; Egeler RM; van Tol MJ; Melief CJ; Hogendoorn PC; Lankester AC
Clin Cancer Res; 2007 Jan; 13(1):206-14. PubMed ID: 17200356
[TBL] [Abstract][Full Text] [Related]
12. Changes in expression of anti-apoptotic protein, cFLIP, in granulosa cells during follicular atresia in porcine ovaries.
Matsuda-Minehata F; Goto Y; Inoue N; Manabe N
Mol Reprod Dev; 2005 Oct; 72(2):145-51. PubMed ID: 16010689
[TBL] [Abstract][Full Text] [Related]
13. Expression of apoptotic tumour necrosis factor receptor-associated factor, caspase recruitment domain and cell death-inducing DFF-45 effector genes in therapy-treated renal cell carcinoma.
Rajandram R; Pat BK; Li J; Johnson DW; Gobe GC
Nephrology (Carlton); 2009 Apr; 14(2):205-12. PubMed ID: 19076291
[TBL] [Abstract][Full Text] [Related]
14. Differential gene expression in anticancer drug- and TRAIL-mediated apoptosis in renal cell carcinomas.
Heikaus S; Casliskan E; Mahotka C; Gabbert HE; Ramp U
Apoptosis; 2007 Sep; 12(9):1645-57. PubMed ID: 17610067
[TBL] [Abstract][Full Text] [Related]
15. The role of apoptosis repressor with a CARD domain (ARC) in the therapeutic resistance of renal cell carcinoma (RCC): the crucial role of ARC in the inhibition of extrinsic and intrinsic apoptotic signalling.
Toth C; Funke S; Nitsche V; Liverts A; Zlachevska V; Gasis M; Wiek C; Hanenberg H; Mahotka C; Schirmacher P; Heikaus S
Cell Commun Signal; 2017 May; 15(1):16. PubMed ID: 28464919
[TBL] [Abstract][Full Text] [Related]
16. Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties.
Mahotka C; Wenzel M; Springer E; Gabbert HE; Gerharz CD
Cancer Res; 1999 Dec; 59(24):6097-102. PubMed ID: 10626797
[TBL] [Abstract][Full Text] [Related]
17. Novel cardiac apoptotic pathway: the dephosphorylation of apoptosis repressor with caspase recruitment domain by calcineurin.
Tan WQ; Wang JX; Lin ZQ; Li YR; Lin Y; Li PF
Circulation; 2008 Nov; 118(22):2268-76. PubMed ID: 19001025
[TBL] [Abstract][Full Text] [Related]
18. Reduction of the antiapoptotic protein cFLIP enhances the susceptibility of human renal cancer cells to TRAIL apoptosis.
Brooks AD; Sayers TJ
Cancer Immunol Immunother; 2005 May; 54(5):499-505. PubMed ID: 15614529
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of nm23-H4 RNA in colorectal and renal tumours.
Hayer J; Engel M; Seifert M; Seitz G; Welter C
Anticancer Res; 2001; 21(4A):2821-5. PubMed ID: 11724361
[TBL] [Abstract][Full Text] [Related]
20. Expression of kidney-specific cadherin in chromophobe renal cell carcinoma and renal oncocytoma.
Adley BP; Gupta A; Lin F; Luan C; Teh BT; Yang XJ
Am J Clin Pathol; 2006 Jul; 126(1):79-85. PubMed ID: 16753598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]